Literature DB >> 11171709

Nutritional intervention in COPD: a systematic overview.

I Ferreira1, D Brooks, Y Lacasse, R Goldstein.   

Abstract

OBJECTIVE: We conducted a systematic overview of randomized controlled trials (RCTs) to clarify the contribution of nutritional supplementation for patients with stable COPD.
METHODS: RCTs were identified from several sources, including the Cochrane Airways Group register of RCTs, a hand search of abstracts presented at international meetings, and consultation with experts. Two reviewers independently selected trials for inclusion, assessed quality, and extracted the data.
RESULTS: Twenty-one reports were classified according to the type, duration of supplementation, and the presence of anabolic substances. High carbohydrate meals were associated with an increase in carbon dioxide production and a decrease in exercise capacity. Short-term crossover studies in which diets of various compositions were administered supported the notion that high carbohydrate loads increase the stress on the ventilatory system. The influence of longer-term supplementation (> 2 weeks) on weight, anthropometry, and exercise capacity varied, without there being a consistent effect. Lean body weight was only occasionally reported and health-related quality of life too rarely to be included as an outcome. The influence of recombinant human growth hormone was disappointing. Anabolic steroids increased body weight and lean body mass, but had little influence on exercise capacity.
CONCLUSION: This systematic overview in patients with COPD supports the notion that those with marginal ventilatory reserve might benefit from a dietary regimen in which a high percentage of calories are supplied by fat. Although there are reports of the benefits of nutritional repletion, trials of > 2 weeks failed to show consistent benefit on body weight. Evaluating nutritional repletion is hampered by the absence of information regarding body composition, exercise, and health-related quality of life. Growth hormone has not been shown to be useful. Further studies are needed to refine the beneficial effects of anabolic steroids as adjunctive agents together with nutritional support and exercise.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171709     DOI: 10.1378/chest.119.2.353

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Sarcopaenia in chronic obstructive pulmonary disease.

Authors:  Michael C Steiner
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

Review 2.  Copd.

Authors:  Huib Am Kerstjens; Dirkje S Postma; Nick Ten Hacken
Journal:  BMJ Clin Evid       Date:  2008-12-15

Review 3.  Copd.

Authors:  Robert Andrew McIvor; Marcel Tunks; David Charles Todd
Journal:  BMJ Clin Evid       Date:  2011-06-06

4.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

5.  Osteoporosis and the risk of temporomandibular disorder in chronic obstructive pulmonary disease.

Authors:  Kuei-Chen Lee; Yung-Tsan Wu; Wu-Chien Chien; Chi-Hsiang Chung; Chih-Hao Shen; Liang-Cheng Chen; Yi-Shing Shieh
Journal:  J Bone Miner Metab       Date:  2020-07-28       Impact factor: 2.626

6.  Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD.

Authors:  Julia Thornton Snider; Anupam B Jena; Mark T Linthicum; Refaat A Hegazi; Jamie S Partridge; Chris LaVallee; Darius N Lakdawalla; Paul E Wischmeyer
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

Review 7.  Anabolic steroid abuse and dependence.

Authors:  Kirk J Brower
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

8.  Resting energy expenditure and carbohydrate oxidation are higher in elderly patients with COPD: a case control study.

Authors:  Bruna Rubi Ramires; Erick Prado de Oliveira; Gustavo Duarte Pimentel; Kátia Cristina Portero McLellan; Darlan Muller Nakato; Márcia Maria Faganello; Maurício Longo Galhardo; Luciene de Souza Venâncio
Journal:  Nutr J       Date:  2012-06-06       Impact factor: 3.271

Review 9.  Effects of anabolic-androgens on brain reward function.

Authors:  Emanuela Mhillaj; Maria G Morgese; Paolo Tucci; Maria Bove; Stefania Schiavone; Luigia Trabace
Journal:  Front Neurosci       Date:  2015-08-26       Impact factor: 4.677

Review 10.  Nutritional support in children and young people with cancer undergoing chemotherapy.

Authors:  Evelyn J Ward; Lisa M Henry; Amanda J Friend; Simone Wilkins; Robert S Phillips
Journal:  Cochrane Database Syst Rev       Date:  2015-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.